Post Hoc Subgroup Analysis by Disease Severity in a Non-Inferiority Trial of Donepezil 27.5 mg Transdermal Formulation in Japanese Patients With Mild-to-Moderate Alzheimer Disease

Alzheimer Disease and Associated Disorders · Published 2026-07-06 · DOI 10.1097/wad.0000000000000738

Free full text

Authors (8)

Yu Nakamura, Takuma Tsushio, Masaya Tanahashi, Hideki Suganami, Takumi Omori, Kenichi Nishiyama, Hiroshi Aoki, Naoki Nagakura

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Nakamura, Y., Tsushio, T., Tanahashi, M., et al. (2026). Post Hoc Subgroup Analysis by Disease Severity in a Non-Inferiority Trial of Donepezil 27.5 mg Transdermal Formulation in Japanese Patients With Mild-to-Moderate Alzheimer Disease. Alzheimer Disease and Associated Disorders. https://doi.org/10.1097/wad.0000000000000738

Related articles

• Language Dominance and Education Considerations in the Neuropsychological Assessment of Southwestern American Indians Using the National Alzheimer Coordinating Center’s Uniform Data Set Version 3 · Alzheimer Disease and Associated Disorders · 2025 · Same journal
• Depression and Anxiety in Stroke-Related and Alzheimer Disease-Related Pseudobulbar Affect: A TriNetX Retrospective Cohort Study · Alzheimer Disease and Associated Disorders · 2026 · Same journal
• Cross-cultural Adaptation and Psychometric Validation of the Modified Social Network Index for Assessing Social Health of People With Dementia in Indonesia · Alzheimer Disease and Associated Disorders · 2025 · Same journal
• White Matter Hyperintensities in Relation to Cognition and Amyloid Burden in a South Korean Cohort With Subjective Cognitive Decline · Alzheimer Disease and Associated Disorders · 2025 · Same journal
• Gut Microbiome Differences Between Early Alzheimer Disease and Idiopathic Normal Pressure Hydrocephalus · Alzheimer Disease and Associated Disorders · 2026 · Same journal
• The Association Between Divorce and Late-life Brain Health in a Racially and Ethnically Diverse Cohort of Older Adults · Alzheimer Disease and Associated Disorders · 2025 · Same journal
• Variation in APOE ε4 Prevalence and Associations With Dementia-Related Outcomes by European Descent Among White Americans · Alzheimer Disease and Associated Disorders · 2025 · Same journal
• County-level School Quality Education Measures During Ninth Grade and Brain Health Imaging Markers in Late Life · Alzheimer Disease and Associated Disorders · 2025 · Same journal
• Risk Factors for Dementia in a Sample of Patients From a Quaternary Care Hospital Network in the United Arab Emirates · Alzheimer Disease and Associated Disorders · 2025 · Same journal
• Behavioral Variant Frontotemporal Dementia With C9orf72 Intermediate Repeat Expansion · Alzheimer Disease and Associated Disorders · 2026 · Same journal